Masimo Prices IPO

Irvine-based Masimo, a developer of medical devices, priced its IPO today, saying in a filing with the SEC that it expects its initial public offering to be priced at between $16.00 and $18.00 per share. Masimo is selling 11,916,626 shares of its common stock on the NASDAQ Global Market as MASI. Masimo is backed by INVESCO Private Capital, Moore Capital Management, DSV Partners, and Franklin Templeton Group. The IPO is being underwritten by Piper Jaffray, Deutsche Bank Securities, Citi, Cowen and Company, and Thomas Weisel Partners.